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A B S T R A C T
In April 2009, a novel influenza A (H1N1) virus was initially detected, and only after two months World Health Orga-
nization declared pandemic, while virus became globally present. We report here a confirmed case of patient suffering
from H1N1 influenza pneumonia in an early period after heart transplantation. Complications of influenza A and B in-
clude viral pneumonia, secondary bacterial pneumonia and possibly acute allograft rejection in the setting of weaning of
immunosuppression. In our case H1N1 influenza pneumonia was treated according to the published guidelines and had
a mild course of disease, but nevertheless emphasis should be put on the prevention of disease applying known general
infection control procedures and vaccination while disease course cannot be predicted.
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Introduction
In April 2009, a novel influenza A (H1N1) virus was
initially detected, and only after two months World Health
Organization declared pandemic, while virus became glo-
bally present1. New H1N1 influenza pandemic very soon
started to impose a broad scope of new issues in trans-
plantation medicine, especially concerning potential do-
nor or recipient infection prevention and treatment in
order to prevent acute allograft rejection2. Therefore, a
new set of guidelines by American Society for Transplan-
tation and International Society for Heart and Lung
Transplantation were published in order to facilitate
clinical judgment2. However, real-life clinical data and
experience are lacking. We report here a confirmed case
of patient suffering from H1N1 influenza pneumonia in
an early period after heart transplantation.
Case Presentation
A 57 year-old man with a history of severe coronary
artery disease previously treated with coronary artery
by-pass graft surgery was admitted to cardiothoracic
clinic in order to be treated with orthotropic heart trans-
plantation (HTx). Transplantation procedure was com-
plicated with brachiocephalic vein injury upon re-sterno-
tomy, prompting its ligation, as well as aortic injury
requiring interpositum graft (Uni-Graft K DV 15 cm / 16
mm) insertion between the native and the aorta of the
allograft. In the early postoperative period patient was
on vasoactive and inotropic support with dominant head
and neck edema which complicated leaning from mecha-
nical ventilation. Since no resolution of the edema was
observed, a control multislice CT-scan with contrast was
preformed which revealed thrombosis of superior vena
cava (SVC). Ten days post-HTx patient was operated
again, with treatment which included partial throm-
bectomy and SVC to right atrium anastomosis with po-
lytetrafluorethylene graft. Procedure was uneventful but
later that day patient became febrile with temperature
38 °C, with suspected pneumonia. On repeated bronchial
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aspirates Enterobacter cloacae (ESBL) was isolated and
patient was treated with ciprofloxacine and meropenem.
Second day he became afebrile and after three weeks was
transferred to cardiology department for further conser-
vative treatment. Routine myocardial biopsies were omitt-
ed due to aforementioned SVC thrombosis, and heart
graft performance was assessed with heart echocardio-
graphy instead. He was treated with standard immuno-
suppressive therapy which included cyclosporine, mofetil
mycofenolate, prednisone, with addition of acyclovir and
myconasole for prevention of viral and fungal infections.
After being three days on a cardiology department he
again became febrile with temperature measuring 39°C
with aches in bones and joints. Both hemocultures and
urinocultures were negative for bacteria, but nasotracheal
swab confirmed H1N1 virus using standard RT-PCR
method, together with chest X-ray which revealed bila-
teral interstitial pneumonia (Figure 1). A treatment with
oseltamivir 75 mg bid was initiated and continued for ten
days, resulting in complete resolution of clinical symp-
toms and X-rays findings. He was discharged home 60
days post HTx.
Discussion
Complications of influenza A and B include viral
pneumonia, secondary bacterial pneumonia and possibly
acute allograft rejection in the setting of weaning of
immunosuppresion1,2. According to the previously pub-
lished papers, recipients of solid organ transplantation
are at higher risk for serious disease from seasonal influ-
enza and one could also preclude that the same states for
the emerging H1N1 virus, subtype of influenza A, espe-
cially if they are on steroid therapy2,3. Our patient had a
mild course of disease accompanied with radiological
signs of pneumonia which did not require intensive care
treatment, while no respiratory distress was manifest.
He had no signs of detoriation in allograft performance
as assessed by periodical echo, probably due to an early
treatment with oseltamivir which was extended to ten
days. We anticipated that prolonged immune suppression
together with specifics of the H1N1 virus are likely to
prolong viral replication, as reported previously2,4. We
presume that infection was acquired during a visit of a
close family member since he also had signs of influenza
but testing was not preformed due to noncompliance.
During an outbreak in our country we’ve put a major em-
phasis on controlling the further H1N1 influenza noso-
comial spreading, including early recognition and testing
of suspicious cases among inpatients and attending staff,
rigorously controlled generally hygiene practice and clo-
se monitoring of compliance with infection control prac-
tice by designated infection control team. Furthermore,
we agree with the recommendation that a preventive
vaccination against H1N1 virus should be considered in
all patients awaiting heat transplantation in order to re-
duce incidence of potentially hazardous complications,
while there is no increase in acute rejection frequency4,5.
The vaccination was not preformed in our patient be-
cause of vaccination was not available on our country at
the time of HTx. Furthermore, we would suggest routine
H1N1 swabs for all transplant patients being pyretic, to-
gether with all contacts, and should be prescribed a pro-
phylactic course of oseltamivir until results.
In conclusion, in our case H1N1 influenza pneumonia
was treated according to the available guidelines and had
a mild course of disease, but nevertheless emphasis should
be put on the prevention of disease applying known gen-
eral infection control procedures and vaccination while
disease course cannot be predicted.
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Fig. 1. Chest X-ray prior to oseltamivir therapy revealing bilat-
eral interstitial pneumonia (in the lower right part of lung there
is a higher position of diaphragm).
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H1N1 INFLUENZA PNEUMONIJA KAO RANA KOMPLIKACIJA NAKON TRANSPLANTACIJE SRCA
– ISKUSTVO IZ KLINI^KE BOLNICE DUBRAVA
S A @ E T A K
U travnju 2009. godine, novi virus influenze A (H1N1) inicijalno je detektiran, i nakon samo dva mjeseca Svjetska
zdravstvena organizacija (WHO) proglasila je pandemiju, s obzirom da je virus postao globalno prisutan. Prikazujemo
klini~ki slu~aj bolesnika koji je lije~en od H1N1 influenza pneumonije u ranom periodu nakon transplantacije srca.
Komplikacije influenza A i B uklju~uju virusnu pneumoniju, sekundarnu bakterijsku pneumoniju i mogu}u akutnu
reakciju odbacivanja alografta tijekom reduciranja imunosupresivne terapije. U na{em slu~aju H1N1 influenza pneu-
monija lije~ena je sukladno dostupnim smjernicama uz blagi tijek bolesti. Bez obzira na ~injenicu blagog tijeka, nagla-
sak bi svakako trebao biti na prevenciji nastanka bolesti uz primjenu poznate op}e poznatih principa kontrole {irenja
bolesti i vakcinacije s obzirom na ~injenicu da tijek bolesti ne mo`e biti predvi|en.
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